Leslie Chong Interview at Biotech Showcase, page-10

Steini:  "About $US 60m mc and on its way to cure many or maybe even all cancer, how undervalued by the Aussie market."

Steini/others:  I agree with you, Steini, that IMU seems to be way, way undervalued!  You blame this on the Aussie market (and I tend to agree that the ASX is not valuing biotech stocks like for instance the US market does).

However, with the exposure that Imugene is getting with their different presentation efforts outside of Australia, that famous "penny should drop" event or moment should be happening eventually and money from outside Australia should flow into this share??

Or is the only way forward a second listing outside of Australia perhaps (not that I think that this will really be necessary)??

Comments most welcome as usual.

wasa